Tool Blocks Blindness in
An overactive thyroid can lead to serious secondary consequences. Individuals with hyperthyroidism and Graves’ disease can experience a multitude of ophthalmic conditions, including bulging eyes, redness and irritation. Some patients develop conditions that can even result in blindness. A new drug, teprotumumab (Tepezza), which has been granted fast-track marketing status, may soon give new hope to sufferers of the rare disease. Read more. Read more.